Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00352261 · ClinicalTrials.gov registry record · Phase 4

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

A Phase 4 study of Barrett's Esophagus, sponsored by AstraZeneca.

Completed
Registry status
Phase 4
Development phase
80
Enrollment target
12
Study locations

NCT00352261 is a Phase 4 study of Barrett's Esophagus that has completed, run by AstraZeneca. The registered enrollment target is 80 participants, below the 521-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (85% lower). The trial reports 12 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00352261, a Phase 4 study of Barrett's Esophagus, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
Phase 4
Development phase
80 participants
Enrollment target
12
Study locations

Study Summary

The purpose of the study is to compare the treatment of esomeprazole 40 mg once daily and lansoprazole 30 mg once daily in controlling intragastric pH in Barrett's Esophagus patients

Conditions Studied

Barrett's Esophagus

Interventions

  • DRUG Esomeprazole
  • DRUG Lansoprazole

Study Locations (12)

Arizona

  • Research Site - Phoenix
  • Research Site - Tucson

Missouri

  • Research Site - Kansas City
  • Research SIte - Springfield

Illinois

  • Research Site - North Chicago

Minnesota

  • Research Site - Rochester

Montana

  • Research Site - Butte

Ohio

  • Research Site - Cleveland

Pennsylvania

  • Research Site - Philadelphia

Tennessee

  • Research Site - Knoxville

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2006-01
Est. Completion 2007-04
Phase Phase 4

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00352261

The ClinicalTrials.gov registry entry for NCT00352261 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 521-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (85% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 2 interventions - of which Esomeprazole is the first listed.

NCT00352261 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Arizona, Missouri, Illinois.

Frequently Asked Questions

What is clinical trial NCT00352261 about?

NCT00352261 is a clinical study titled "An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients". The purpose of the study is to compare the treatment of esomeprazole 40 mg once daily and lansoprazole 30 mg once daily in controlling intragastric pH in Barrett's Esophagus patients

What is the current status of trial NCT00352261?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2006-01. Estimated completion is 2007-04.

What conditions does trial NCT00352261 study?

This clinical trial studies the following conditions: Barrett's Esophagus.

What interventions are being tested in trial NCT00352261?

The interventions under investigation include: Esomeprazole (DRUG), Lansoprazole (DRUG).

Who is sponsoring clinical trial NCT00352261?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00352261 being conducted?

This trial has 12 study locations across Arizona, Illinois, Minnesota, Missouri, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Barrett's Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Barrett's Esophagus

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.